Overview of CRISPR
CRISPR represents a groundbreaking innovation that is altering lives and creating significant impact in the medical domain. CRISPR, which is an abbreviation for “Clustered Regularly Interspaced Short Palindromic Repeats,” exists in prokaryotes—microscopic, single-celled organisms devoid of organelles. These sequences are embedded within the genomes of prokaryotes, which compile a cell’s DNA in clusters.
As a gene editing mechanism, CRISPR is utilized to alter specific DNA segments to address severe illnesses. Its ingenuity lies in its ability to protect the organism against viral attacks by integrating the foreign DNA into its own genome, which enables it to identify and eliminate the virus in subsequent encounters. What stands out is that, in comparison to alternative gene editing techniques, CRISPR is significantly more accurate and simpler to program, facilitating a more straightforward sequence modification process. While most gene-editing tools typically employ a single protein, CRISPR utilizes RNA-guided targeting coupled with the Cas9 enzyme.
Mechanism of CRISPR
CRISPR operates by capitalizing on a natural defense system present in bacteria that enables them to detect and eradicate viral attackers. When a virus infiltrates a bacterial cell (a prokaryote), the bacterium retains a portion of the invader’s DNA within its own genome as a genetic “memory.” This allows the bacterium to identify and react more efficiently to future infections.
In the context of gene editing, this system is modified with two essential elements: the Cas9 enzyme, which acts like molecular scissors to cleave DNA, and guide RNA, which instructs Cas9 to the exact genetic sequence requiring modification. After the targeted DNA is severed, the cell’s intrinsic repair systems take over, permitting scientists to implement alterations to the genetic blueprint.
Unlike previous tools that depended on difficult-to-reprogram proteins, CRISPR’s RNA-guided approach is more adaptable, simpler to design, and exhibits high precision. This ease and accuracy have enabled CRISPR to be utilized across medicine, agriculture, manufacturing, and microbiology—such as engineering microbes to enhance product yields. However, as this piece examines, the expansion of capabilities raises increasing ethical dilemmas, especially concerning germline editing and genetic enhancement.
First Patient to Receive a Tailored CRISPR Treatment
In February 2025, the world saw its inaugural personalized CRISPR treatment for a baby named KJ, aimed at addressing a deficiency in Carbamoyl Phosphate Synthetase 1 (CPS1)—an enzyme crucial for converting ammonia (generated during protein metabolism) into urea. A team headed by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru at the Children’s Hospital of Philadelphia crafted this treatment after years of research in gene editing alongside other medical professionals.
Their research concentrated on conditions affecting the urea cycle, which results in harmful ammonia accumulation, damaging organs such as the brain and liver. They customized the treatment specifically for KJ’s type of CPS1 deficiency by leveraging preclinical studies on similar cases.
Thus far, the only CRISPR treatments authorized by the U.S. FDA have been for more prevalent ailments like sickle cell disease and beta thalassemia, impacting tens of thousands of patients. In KJ’s scenario, his treatment was formulated within six months of his birth, targeting his unique CPS1 variant. The team developed a base editing therapy delivered via lipid nanoparticles to his liver to rectify the defective enzyme.
The treatment administered in February was the first of a trilogy of doses; KJ received the next two in March and April 2025. As of his final dosage, he has not manifested any serious side effects, demonstrates heightened tolerance to dietary protein, and requires a reduced dosage of medication to regulate ammonia levels. Although continuous monitoring will be necessary, Ahrens-Nicklas indicates that the observed outcomes so far are encouraging.
Ethical Implications of CRISPR
Like any revolutionary technology, CRIS